source
- Vertex to buy Crinetics for $10 billion, adding acromegaly drug PalsonifyVertex Pharmaceuticals announced a $10 billion acquisition of Crinetics Pharmaceuticals, marking the largest deal in Vertex’s history. The purchase gives Vertex control of Crinetics’ marketed ther…
- Novartis to buy Myricx Bio for up to $1.5 billion, adding two novel ADCs to its oncology portfolioNovartis announced it will acquire Myricx Bio, a UK‑based biotech that develops antibody drug conjugates (ADCs), in a move to broaden its oncology pipeline. The transaction is valued at up to $1.5…